Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer<sup>®</sup>-Accredited Facilities in the United States

Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer<sup>®</sup>-Accredited Facilities in the United States

Purpose: To investigate IMT use and survival in real-world stage IVB cervical cancer patients outside randomized clinical trials. Methods: Patients diagnosed with stage IVB cervical cancer during 2013–2019 in the National Cancer Database and treated with chemotherapy (CT) ± external beam radiation (...

Full description

Bibliographic Details
Main Authors: Collin A. Sitler, Chunqiao Tian, Chad A. Hamilton, Michael T. Richardson, John K. Chan, Daniel S. Kapp, Charles A. Leath, Yovanni Casablanca, Christina Washington, Nicole P. Chappell, Ann H. Klopp, Craig D. Shriver, Christopher M. Tarney, Nicholas W. Bateman, Thomas P. Conrads, George Larry Maxwell, Neil T. Phippen, Kathleen M. Darcy
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Cancers
Subjects:
cervical cancer
survival
immunotherapy
chemotherapy
radiation
targeted therapy
Online Access:https://www.mdpi.com/2072-6694/16/5/1071

Internet

https://www.mdpi.com/2072-6694/16/5/1071

Similar Items